State MI
Clinical Trials in Michigan
Recruiting clinical trials with at least one study location in Michigan. Data updated daily from ClinicalTrials.gov.
Top Conditions in Michigan
NCT04967989 Phase 3
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
Condition
Glaucoma and Ocular Hypertension
Enrollment
790 pts
Location
United States, Canada
Sponsor
University of Pittsburgh
NCT01016613 N/A
Recruiting
Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Cen...
Condition
Chronic Kidney Disease
Enrollment
1,800 pts
Location
United States
Sponsor
University of Michigan
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05588388 Phase 2
Recruiting
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in ...
Condition
Extensive-stage Small-cell Lung Cancer
Enrollment
39 pts
Location
United States
Sponsor
Kamya Sankar
NCT06163326 Phase 3
Recruiting
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Partici...
Condition
Vitiligo
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Pfizer
NCT04623424 N/A
Recruiting
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
Condition
Stem Cell Transplant Complications
Enrollment
255 pts
Location
United States
Sponsor
Henry Ford Health System
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease...
Condition
Intestinal Failure Associated Liver Disease
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory M...
Condition
Multiple Myeloma
Enrollment
387 pts
Location
United States, Belgium, Germany
Sponsor
Regeneron Pharmaceuticals
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, Germany
Sponsor
Boston Scientific Corporation
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT02703220 Phase 4
Recruiting
Sleep Apnea in Elderly
Condition
Sleep Apnea
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT02922894 Phase 4
Recruiting
Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury
Condition
Sleep Apnea
Enrollment
100 pts
Location
United States
Sponsor
John D. Dingell VA Medical Cen
NCT06424327 N/A
Recruiting
A Registry for People With Lung Cancer
Condition
Lung Cancer
Enrollment
600 pts
Location
United States, Canada
Sponsor
Memorial Sloan Kettering Cance
NCT06177717 N/A
Recruiting
Deep Functional Phenotyping of the ALA Lung Health Cohort
Condition
Lung Diseases
Enrollment
1,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06904391 N/A
Recruiting
Education & Mentorship of Advanced Practice Providers to Increase Community-base...
Condition
Other
Enrollment
97 pts
Location
United States
Sponsor
Wake Forest University Health
NCT06953960 Phase 1, Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453...
Condition
Multiple Myeloma
Enrollment
130 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT06091254 Phase 3
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...
Condition
Follicular Lymphoma (FL)
Enrollment
822 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
NCT06045754 Phase 4
Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Usteki...
Condition
Crohn's Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Takeda
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer